Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag symbols : Xncr save search
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
Published: 2023-11-02 (Crawled : 18:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.09%
H: 1.03%
C: 0.91%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 1.32%
H: 0.45%
C: -1.19%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 2.22%
H: 0.6%
C: -9.4%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.28%
H: 1.0%
C: -0.46%
presentation meeting
Incyte Announces Data from Across its Oncology Portfolio will be Presented at the AACR Annual Meeting 2023
Published: 2023-03-14 (Crawled : 01:00) - biospace.com/
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: 0.31%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 1.2%
H: 0.17%
C: -1.67%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: -1.79%
H: 3.39%
C: 3.39%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.18%
H: 1.06%
C: 0.94%
meeting
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-08-02 (Crawled : 12:00) - biospace.com/
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -1.33%
H: 0.78%
C: -1.06%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: -0.32%
H: 5.09%
C: 3.9%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: -3.37%
H: 3.3%
C: 0.92%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -4.39%
H: 0.2%
C: -1.92%
results
Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting
Published: 2022-05-26 (Crawled : 11:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 3.5%
H: 2.14%
C: 0.19%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 1.26%
H: 0.95%
C: -1.13%
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 2.08%
H: 1.96%
C: -0.77%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 2.45%
H: 0.92%
C: -2.03%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 2.12%
H: 4.06%
C: 1.39%
results
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.49%
H: 0.56%
C: -0.07%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 2.7%
H: 1.01%
C: 0.85%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -1.93%
H: 0.19%
C: -3.14%
financial results results
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.6%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 0.55%
H: 1.32%
C: 1.03%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: -2.43%
H: 0.88%
C: 0.44%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.7%
H: 0.31%
C: 0.04%
financial results results
Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: -1.25%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.82%
H: 0.28%
C: -0.06%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: -5.61%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: -4.71%
H: 0.33%
C: -2.65%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -2.37%
H: 2.04%
C: -2.95%
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.